Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Hicks

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
Genes, Chromosomes & Cancer|July 11, 2007
Candidate glioblastoma development gene identification using concordance between copy number abnormalities and gene expression level changesKen C Lo, Michael R Rossi, Jeffrey LaDuca, et al.
Advances in Radiation Oncology|March 23, 2026
Case Series of Breast Carcinoma Erysipeloides Confined Within a Prior Radiation Therapy Treatment FieldKeaton A Rummel, Aria Shakeri, Anna Weiss, et al.
Histopathology|March 14, 2014
Pathological features and clinical outcomes of breast cancer according to levels of oestrogen receptor expressionZhang Zhang, Jianmin Wang, Kristin A Skinner, et al.
American Journal of Clinical Pathology|March 1, 2023
Interobserver and Interantibody Reproducibility of HER2 Immunohistochemical Scoring in an Enriched HER2-Low-Expressing Breast Cancer CohortCansu Karakas, Haley Tyburski, Bradley M Turner, et al.
Histopathology|July 8, 2024
Best practices for achieving consensus in HER2-low expression in breast cancer: current perspectives from practising pathologistsGary Tozbikian, Marilyn M Bui, David G Hicks, et al.
The American Journal of Pathology|May 26, 2007
Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cellsKhalid Sossey-Alaoui, Alfiya Safina, Xiurong Li, et al.
BMC Cancer|December 20, 2018
A novel detection methodology for HER2 protein quantitation in formalin-fixed, paraffin embedded clinical samples using fluorescent nanoparticles: an analytical and clinical validation studyDavid G Hicks, Brandon Buscaglia, Hideki Goda, et al.
Human Pathology|June 2, 2016
p53 alteration in morphologically normal/benign breast tissue in patients with triple-negative high-grade breast carcinomas: breast p53 signature?Xi Wang, Moritz Stolla, Brian Z Ring, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 19, 2004
Immunohistochemical evaluation of microphthalmia-associated transcription factor expression in giant cell lesionsRaja R Seethala, John R Goldblum, David G Hicks, et al.
The American Journal of Surgical Pathology|August 13, 2005
The influence of polysomy 17 on HER2 gene and protein expression in adenocarcinoma of the breast: a fluorescent in situ hybridization, immunohistochemical, and isotopic mRNA in situ hybridization studyErinn Downs-Kelly, Brian J Yoder, Mark Stoler, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Genes, Chromosomes & Cancer|July 11, 2007
Candidate glioblastoma development gene identification using concordance between copy number abnormalities and gene expression level changesKen C Lo, Michael R Rossi, Jeffrey LaDuca, et al.
Advances in Radiation Oncology|March 23, 2026
Case Series of Breast Carcinoma Erysipeloides Confined Within a Prior Radiation Therapy Treatment FieldKeaton A Rummel, Aria Shakeri, Anna Weiss, et al.
Histopathology|March 14, 2014
Pathological features and clinical outcomes of breast cancer according to levels of oestrogen receptor expressionZhang Zhang, Jianmin Wang, Kristin A Skinner, et al.
American Journal of Clinical Pathology|March 1, 2023
Interobserver and Interantibody Reproducibility of HER2 Immunohistochemical Scoring in an Enriched HER2-Low-Expressing Breast Cancer CohortCansu Karakas, Haley Tyburski, Bradley M Turner, et al.
Histopathology|July 8, 2024
Best practices for achieving consensus in HER2-low expression in breast cancer: current perspectives from practising pathologistsGary Tozbikian, Marilyn M Bui, David G Hicks, et al.
The American Journal of Pathology|May 26, 2007
Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cellsKhalid Sossey-Alaoui, Alfiya Safina, Xiurong Li, et al.
BMC Cancer|December 20, 2018
A novel detection methodology for HER2 protein quantitation in formalin-fixed, paraffin embedded clinical samples using fluorescent nanoparticles: an analytical and clinical validation studyDavid G Hicks, Brandon Buscaglia, Hideki Goda, et al.
Human Pathology|June 2, 2016
p53 alteration in morphologically normal/benign breast tissue in patients with triple-negative high-grade breast carcinomas: breast p53 signature?Xi Wang, Moritz Stolla, Brian Z Ring, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 19, 2004
Immunohistochemical evaluation of microphthalmia-associated transcription factor expression in giant cell lesionsRaja R Seethala, John R Goldblum, David G Hicks, et al.
The American Journal of Surgical Pathology|August 13, 2005
The influence of polysomy 17 on HER2 gene and protein expression in adenocarcinoma of the breast: a fluorescent in situ hybridization, immunohistochemical, and isotopic mRNA in situ hybridization studyErinn Downs-Kelly, Brian J Yoder, Mark Stoler, et al.
Pageof 14